The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA

被引:7
|
作者
Nix, David A. [1 ]
Hellwig, Sabine [2 ]
Conley, Christopher [1 ]
Thomas, Alun [3 ,4 ]
Fuertes, Carrie L. [5 ]
Hamil, Cindy L. [5 ]
Bhetariya, Preetida J. [6 ]
Garrido-Laguna, Ignacio [1 ]
Marth, Gabor T. [6 ]
Bronner, Mary P. [5 ]
Underhill, Hunter R. [7 ,8 ]
机构
[1] Univ Utah, Huntsman Canc Inst, Sch Med, Salt Lake City, UT USA
[2] ARUP Labs, Salt Lake City, UT USA
[3] Univ Utah, Dept Family & Preventat Med, Div Genet Epidemiol, Salt Lake City, UT USA
[4] Univ Utah, Dept Family & Preventat Med, Div Publ Hlth, Salt Lake City, UT USA
[5] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[6] Univ Utah, Dept Human Genet, Salt Lake City, UT USA
[7] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA
[8] Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA
来源
PLOS ONE | 2020年 / 15卷 / 02期
基金
美国国家卫生研究院;
关键词
CLONAL HEMATOPOIESIS; RARE MUTATIONS; CANCER; PLASMA; QUANTIFICATION;
D O I
10.1371/journal.pone.0229063
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Challenges with distinguishing circulating tumor DNA (ctDNA) from next-generation sequencing (NGS) artifacts limits variant searches to established solid tumor mutations. Here we show early and random PCR errors are a principal source of NGS noise that persist despite duplex molecular barcoding, removal of artifacts due to clonal hematopoiesis of indeterminate potential, and suppression of patterned errors. We also demonstrate sample duplicates are necessary to eliminate the stochastic noise associated with NGS. Integration of sample duplicates into NGS analytics may broaden ctDNA applications by removing NGS-related errors that confound identification of true very low frequency variants during searches for ctDNA without a priori knowledge of specific mutations to target.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] High-throughput mutational analysis in cell-free DNA by targeted next-generation sequencing
    Tam, Nga Wan Rachel
    Shames, David
    Darbonne, Walter
    [J]. CANCER RESEARCH, 2016, 76
  • [32] Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA
    Supplee, Julianna G.
    Milan, Marina S. D.
    Lim, Lee P.
    Potts, Kristy T.
    Sholl, Lynette M.
    Oxnard, Geoffrey R.
    Paweletz, Cloud P.
    [J]. LUNG CANCER, 2019, 134 : 96 - 99
  • [33] Low-Input Method for Cell-Free DNA Quality Assessment Improves Circulating Tumor DNA Next-Generation Sequencing Assay Performance
    Lovejoy, A.
    Hinzmann, B.
    Beckert, S.
    McClintock, K.
    Mayol, K.
    Pimento, M.
    Williams, C.
    Huynh, S.
    Harrell, A.
    Lefkowitz, J.
    Dinh, V. Van
    Deodhar, N.
    Ma, X.
    Jiang, J.
    Klass, D.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1234 - 1234
  • [34] Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor
    Helman, Elena
    Minh Nguyen
    Karlovich, Chris A.
    Despain, Darrin
    Choquette, A. Karin
    Spira, Alexander, I
    Yu, Helena A.
    Camidge, D. Ross
    Harding, Thomas C.
    Lanman, Richard B.
    Simmons, Andrew D.
    [J]. CLINICAL LUNG CANCER, 2018, 19 (06) : 518 - +
  • [35] Somatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphoma
    Bessi, Lucile
    Viailly, Pierre-Julien
    Bohers, Elodie
    Ruminy, Philippe
    Maingonnat, Catherine
    Bertrand, Philippe
    Vasseur, NasrinSarafan
    Beaussire, Ludivine
    Cornic, Marie
    Etancelin, Pascaline
    Camus, Vincent
    Picquenot, Jean-Michel
    Tilly, Herve
    Stamatoullas, Aspasia
    Jardin, Fabrice
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 498 - 502
  • [36] Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
    Thompson, Jeffrey C.
    Yee, Stephanie S.
    Troxel, Andrea B.
    Savitch, Samantha L.
    Fan, Ryan
    Balli, David
    Lieberman, David B.
    Morrissette, Jennifer D.
    Evans, Tracey L.
    Bauml, Joshua
    Aggarwal, Charu
    Kosteva, John A.
    Alley, Evan
    Ciunci, Christine
    Cohen, Roger B.
    Bagley, Stephen
    Stonehouse-Lee, Susan
    Sherry, Victoria E.
    Gilbert, Elizabeth
    Langer, Corey
    Vachani, Anil
    Carpenter, Erica L.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (23) : 5772 - 5782
  • [37] Circulating cell-free tumor DNA (cfDNA) analysis of 50-genes by next-generation sequencing (NGS) in the prospective MOSCATO trial
    Ileana, Ecaterina
    Jovelet, Cecile
    Le Deley, Marie-Cecile
    Massard, Christophe
    Motte, Nelly
    Hollebecque, Antoine
    Boichard, Amelie
    Ferte, Charles
    Postel-Vinay, Sophie
    Rosellini, Silvia
    Ngo-Camus, Maud
    De Baere, Thierry
    Vielh, Philippe
    Richon, Catherine
    Laporte, Melanie
    Gouissem, Siham
    Loriot, Yohann
    Bahleda, Rastilav
    Gazzah, Anas
    Varga, Andrea
    Vassal, Gilles
    Eggermont, Alexander
    Andre, Fabrice
    Soria, Jean-Charles
    Lacroix, Ludovic
    [J]. CANCER RESEARCH, 2015, 75
  • [38] Cell-free DNA diagnostics in transplantation utilizing next generation sequencing
    Jackson, Annette M.
    Amato-Menker, Carly
    Bettinotti, Maria
    [J]. HUMAN IMMUNOLOGY, 2021, 82 (11) : 850 - 858
  • [39] Metagenomic next-generation sequencing of plasma cell-free DNA improves the early diagnosis of suspected infections
    Hui Zhang
    Ruobing Liang
    Yunzhu Zhu
    Lifen Hu
    Han Xia
    Jiabin Li
    Ying Ye
    [J]. BMC Infectious Diseases, 24
  • [40] Next-Generation Sequencing of Cell-Free DNA Extracted from Pleural Effusion Supernatant: Applications and Challenges
    Patel, Ami
    Rosado, Lucelina
    Cong, Lin
    Alperstein, Susan
    Rennert, Hanna
    Siddiqui, Momin
    Heymann, Jonas
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 403 - 404